121 results
·
34ms
·
Sources: EU EUDAMED, US FDA
ABSORBENT PAD -- MODIFICATION
FDA 510(k)
FDA Class 1
·General, Plastic Surgery
Arthrex®
FDA UDI
ARTHREX, INC.·00888867059481·TRIAL, MEDIUM, PEGGED GLENOID
TM ARDIS INTERBODY SYSTEM INSERTER
FDA 510(k)
FDA Class 2
·Orthopedic
SMALL VOLUME NEBULIZER
FDA 510(k)
FDA Class 2
·Anesthesiology
RADIFOCUS GLIDEWIRE M
FDA Adverse Event
Injury
·TERUMO CORPORATION, ASHITAKA·Product code DQX·January 22, 2018
UNK DEPUY DURALOC CUP
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS, INC.·Product code LPH·December 9, 2010
OT ULTRA2 METER
FDA Adverse Event
Injury
·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·January 22, 2013
INTERSTIM II
FDA Adverse Event
Injury
·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code EZW·July 9, 2014
TRIAL, MEDIUM, PEGGED GLENOID
FDA Adverse Event
Malfunction
·ARTHREX, INC.·Product code HWT·February 4, 2025
TRIAL, MEDIUM, PEGGED GLENOID
FDA Adverse Event
Malfunction
·ARTHREX, INC.·Product code HWT·July 3, 2023
TRIAL, MEDIUM, PEGGED GLENOID
FDA Adverse Event
Malfunction
·ARTHREX, INC.·Product code HWT·May 3, 2024
LAPRO-CLIP
FDA Adverse Event
Malfunction
·COVIDIEN LP LLC NORTH HAVEN·Product code GCJ·June 4, 2025
RADIFOCUS GLIDEWIRE
FDA Adverse Event
Injury
·TERUMO CORPORATION, ASHITAKA·Product code DQX·December 29, 2025
RADIFOCUS GLIDEWIRE
FDA Adverse Event
Injury
·TERUMO MEDICAL CORPORATION·Product code DQX·May 16, 2024
RADIFOCUS GUIDEWIRE M
FDA Adverse Event
Malfunction
·TERUMO CORPORATION, ASHITAKA·Product code DQX·May 21, 2021
RADIFOCUS GLIDEWIRE
FDA Adverse Event
Injury
·TERUMO CORPORATION, ASHITAKA·Product code DQX·October 6, 2025
RADIFOCUS GUIDEWIRE M
FDA Adverse Event
Injury
·TERUMO MEDICAL CORPORATION·Product code DQX·September 15, 2023
GUIDE WIRE M
FDA Adverse Event
Injury
·TERUMO CORPORATION, ASHITAKA·Product code DQX·June 25, 2025
RADIFOCUS GUIDEWIRE
FDA Adverse Event
Injury
·TERUMO MEDICAL CORPORATION·Product code DQX·December 5, 2023
RADIFOCUS GUIDEWIRE M
FDA Adverse Event
Injury
·TERUMO CORPORATION, ASHITAKA·Product code DQX·April 3, 2018